0001209191-18-041298.txt : 20180703
0001209191-18-041298.hdr.sgml : 20180703
20180703181640
ACCESSION NUMBER: 0001209191-18-041298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180701
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FARRELL STEPHEN C
CENTRAL INDEX KEY: 0001188757
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 18938835
MAIL ADDRESS:
STREET 1: 701 EDGEWATER DRIVE
STREET 2: SUITE 360
CITY: WAKEFIELD
STATE: MA
ZIP: 01880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTIME INC
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-01
0
0000876343
BIOTIME INC
BTX
0001188757
FARRELL STEPHEN C
3021 NE 23 COURT
FORT LAUDERDALE
FL
33305
1
0
0
0
Common Shares, no par vaule
97450
D
Option to Purchase Common Shares
2.06
2018-07-01
4
A
0
40000
0.00
A
2023-06-30
Common Shares
40000
40000
D
Option to Purchase Common Shares
3.15
2022-06-30
Common Shares
20000
20000
D
Option to Purchase Common Shares
2.72
2021-06-30
Common Shares
20000
20000
D
Option to Purchase Common Shares
3.57
2020-06-30
Common Shares
20000
20000
D
Option to Purchase Common Shares
3.11
2019-06-30
Common Shares
20000
20000
D
Will become exercisable on June 30, 2019, based upon continued service on the board of directors.
Became exercisable in four equal quarterly installments after the date of grant on July 1, 2017.
Became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.
Became exercisable in four equal quarterly installments after the date of grant on July 1, 2015.
Became exercisable in four equal quarterly installments after the date of grant on July 1, 2014.
/s/Stephen C. Farrell
2018-07-03